Pharmacist given GPhC warning after child given orodispersible olanzapine instead of lansoprazole

Date of Decision: November 17, 2026

Registrant's Role: Pharmacist

Allegations:

  • On 16 June 2025, the registrant dispensed olanzapine 15 mg orodispersible tablets instead of lansoprazole 15 mg orodispersible tablets to a child.
  • The registrant failed to carry out appropriate clinical and suitability checks before and when dispensing the wrong medication to the child or their representative.
  • The failings caused actual harm. The child was admitted to hospital for treatment.

Outcome: Warning issued

GPhC Standards Breached:

  • Standard 1 – Pharmacy professionals must provide person-centred care.
  • Standard 3 – Pharmacy professionals must communicate effectively.

Case Summary

Allegations

A child who was prescribed lansoprazole 15 mg orodispersible tablets received olanzapine 15 mg orodispersible tablets instead. The GPhC’s published warning records that the child suffered actual harm and was admitted to hospital for treatment. The incident took place on 16 June 2025 while the registrant was working as a registered pharmacy professional.

The allegation covered both the supply of the wrong medicine and the checks leading up to that supply. The warning describes a failure to carry out appropriate clinical and suitability checks before and at the point of dispensing the medication to the child or their representative. It describes the medication supplied in error as high risk.

Continue Reading the Full Case

Create a free account or log in to access the complete case summary.

  • Full allegations considered by the GPhC/PSNI
  • Panel findings and reasoning
  • Outcome of the investigation
  • Sanctions considered and imposed on the Pharmacist
  • Key professional learning points

Register for Free or Log In

Original Case Document

The original determination document is available to registered users.

Register for Free or Log In

Leave a Reply